Epstein Secrets

From: "Jeffrey E." <[email protected]> To: Subject: Fwd: Alzhe

i wanted to talk to him about Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 2017 To: Jeffrey Epstein <[email protected]> Begin forwarded message: From:- > Datil.8 2017 at 3:38:14 AM EDT To: < > Subject: FW: Alzheimer's R&D updates - March

Alzheimer's R&D updates - March 2017 To: Jeffrey Epstein <[email protected]> Begin forwarded message:

From: "Jeffrey E." <[email protected]> To: Subject: Fwd: A

erved here could result in LRP1 as a potential drug target. Yes, it is in a mouse model...so may not be 100% predictable or translatable in humans. David Holtzman (St Louis), who you met last year is a co-author on this study. Liu CC, Hu J, Zhao N, Wang J, Na W, Cirrito JR, Kanekiyo T, Holtzman DM, Bu G. 2017

15:25:52 +0000 Good morning - well received, thank you very much. Executive Assistant to Ronald S. Lauder RSL Management Corporation T F From: Jeffrey Epstein Date: Saturday, April 8, 2017 at 9:30 AM Subject: Fwd: Alzheimer's R&D updates - March 2017 Morning! please forward below to Ronald. ... tell him

R&D updates - March 2017 Morning! please forward below to Ronald. ... tell him Gates has decided to spend some money on alzhhiemers, that is what Jeffrey wanted to talk to him about Thanks, Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 201

RSL Management Corporation T F From: Jeffrey Epstein Date: Saturday, April 8, 2017 at 9:30 AM Subjec

erved here could result in LRP1 as a potential drug target. Yes, it is in a mouse model...so may not be 100% predictable or translatable in humans. David Holtzman (St Louis), who you met last year is a co-author on this study. Liu CC Hu J, Zhao N, Wang J, Na W, Cirrito JR, Kanekiyo T, Holtzman DM, Bu G. 2017.

From: To: Jeffrey Epstein <[email protected]> Subject: Fwd: Alzheimer's R&D updates - March 2017 Date: Sat, 08 Apr 2017 13:17:58 +0000 Begin forwarded message: From: N

From: To: Jeffrey Epstein <[email protected]> Subject: Fwd: Alzheimer'

From: To: Jeffrey Epstein <[email protected]> Subject: Fwd: Al

erved here could result in LRP1 as a potential drug target. Yes, it is in a mouse model...so may not be 100% predictable or translatable in humans. David Holtzman (St Louis), who you met last year is a co-author on this study. Liu CC, Hu .1, Zhao N, Wang J, Na W Cirrito JR, Konekiyo T, Holtzman DM, Bu G. 2017

at, 08 Apr 2017 13:30:11 +0000 Morning! please forward below to.. ... tell him Gates has decided to spend some money on alzhhiemers, that is what Jeffrey wanted to talk to him about Thanks, Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 201

d result in LRP1 as a potential drug target. EFTA00449178 Yes, it is in a mouse model...so may not be 100% predictable or translatable in humans. David Holtzman (St Louis), who you met last year is a co-author on this study. Liu CC, Hu J, Zhao N, Wang J, Na W, Cirrito JR, Kanekiyo T, Holtzman DM, Bu G. 2017